nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Accelerating point-of-care HCV viral load testing
|
Tang, Weiming |
|
|
8 |
3 |
p. 203-204 |
artikel |
2 |
Addressing the risks of broad-scale H pylori eradication
|
Leja, Mārcis |
|
|
8 |
3 |
p. 201-203 |
artikel |
3 |
A national programme to scale-up decentralised hepatitis C point-of-care testing and treatment in Australia
|
Grebely, Jason |
|
|
8 |
3 |
p. 204-207 |
artikel |
4 |
Development and validation of the Gender-Equity Model for Liver Allocation (GEMA) to prioritise candidates for liver transplantation: a cohort study
|
Rodríguez-Perálvarez, Manuel Luis |
|
|
8 |
3 |
p. 242-252 |
artikel |
5 |
Distilling the message: Irish plans for alcohol warning labels
|
The Lancet Gastroenterology & Hepatology, |
|
|
8 |
3 |
p. 199 |
artikel |
6 |
Ethnicity, diversity, and inclusion in UK gastroenterology
|
Verma, Ajay M |
|
|
8 |
3 |
p. 207-209 |
artikel |
7 |
Friends, Lovers, and the Big Terrible Thing
|
Sherwood-Martin, Hollie |
|
|
8 |
3 |
p. 214 |
artikel |
8 |
Genomic diagnosis and care co-ordination for monogenic inflammatory bowel disease in children and adults: consensus guideline on behalf of the British Society of Gastroenterology and British Society of Paediatric Gastroenterology, Hepatology and Nutrition
|
Kammermeier, Jochen |
|
|
8 |
3 |
p. 271-286 |
artikel |
9 |
Impact of hepatitis C virus point-of-care RNA viral load testing compared with laboratory-based testing on uptake of RNA testing and treatment, and turnaround times: a systematic review and meta-analysis
|
Trickey, Adam |
|
|
8 |
3 |
p. 253-270 |
artikel |
10 |
Research in Brief
|
Baker, Holly |
|
|
8 |
3 |
p. 213 |
artikel |
11 |
Second-line levofloxacin-based quadruple therapy versus bismuth-based quadruple therapy for Helicobacter pylori eradication and long-term changes to the gut microbiota and antibiotic resistome: a multicentre, open-label, randomised controlled trial
|
Liou, Jyh-Ming |
|
|
8 |
3 |
p. 228-241 |
artikel |
12 |
Thank you to The Lancet Gastroenterology & Hepatology's statistical and peer reviewers in 2022
|
The Lancet Gastroenterology & Hepatology's Editors, |
|
|
8 |
3 |
p. e1-e3 |
artikel |
13 |
Trainee engagement in the Improving Quality in Liver Services accreditation programme
|
Maurice, James B |
|
|
8 |
3 |
p. 209-210 |
artikel |
14 |
Trastuzumab plus FOLFOX for HER2-positive biliary tract cancer
|
Ayasun, Ruveyda |
|
|
8 |
3 |
p. 211 |
artikel |
15 |
Trastuzumab plus FOLFOX for HER2-positive biliary tract cancer – Authors' reply
|
Lee, Choong-kun |
|
|
8 |
3 |
p. 211-212 |
artikel |
16 |
Treatment withdrawal in Crohn's disease: slowly becoming clearer
|
Fredericks, Ernst |
|
|
8 |
3 |
p. 200-201 |
artikel |
17 |
Withdrawal of infliximab or concomitant immunosuppressant therapy in patients with Crohn's disease on combination therapy (SPARE): a multicentre, open-label, randomised controlled trial
|
Louis, Edouard |
|
|
8 |
3 |
p. 215-227 |
artikel |